Sodium Diuril (Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.))


Welcome to the PulseAid listing for the Sodium Diuril drug offered from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.). This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
NON-PROPRIETARY NAME: chlorothiazide sodium
SUBSTANCE NAME: CHLOROTHIAZIDE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1958-10-03
END MARKETING DATE: 0000-00-00


Sodium Diuril HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Diuril from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
LABELER NAME: Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/18mL)
START MARKETING DATE: 1958-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76478-711_aebe3b0a-b212-49cf-ae95-73f6f4be2e7f
PRODUCT NDC: 76478-711
APPLICATION NUMBER: NDA011145

Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Chlorothiazide Sodium
American Regent, Inc.Chlorothiazide Sodium
Fresenius Kabi USA, LLCChlorothiazide
Mylan Institutional LLCchlorothiazide sodium
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)Sodium Diuril
Sagent Pharmaceuticalschlorothiazide sodium